​

Funding Round

Series C - Avalyn Pharma

Series C - Avalyn Pharma

Investment Firm

Overview

Avalyn Pharma is a biopharma company developing therapies for the treatment of idiopathic pulmonary fibrosis and other respiratory diseases.

Announced Date

Sep 27, 2023

Closed on Date

Sep 27, 2023

Funding Type

Series C

Highlights

Location

United States, North America

Social

Investor Lead

SR One

SR One

SR One is a early_stage_venture and late_stage_venture and post_ipo and private_equity and seed and venture firm.

Perceptive Advisors

Perceptive Advisors

Perceptive Advisors is a debt and early_stage_venture and late_stage_venture and post_ipo and private_equity and venture firm.

Participant Investors

10

Investor Name
Participant InvestorNovo Holdings
Participant InvestorRiverVest
Participant InvestorF-Prime Capital
Participant InvestorWellington Management
Participant InvestorNorwest Venture Partners

Round Details and Background

Avalyn Pharma raised $175000000 on 2023-09-27 in Series C

Avalyn Pharma is a biopharma company developing therapies for the treatment of idiopathic pulmonary fibrosis and other respiratory diseases.

Company Funding History

3

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jan 01, 2017
Series A - Avalyn Pharma
7-62.0M
Apr 27, 2020
Series B - Avalyn Pharma
6-35.5M
Sep 27, 2023
Series C - Avalyn Pharma
14-175.0M

Recent Activity

There is no recent news or activity for this profile.